Thematic review series: The Immune System and Atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?
Open Access
- 1 March 2005
- journal article
- review article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 46 (3), 389-403
- https://doi.org/10.1194/jlr.r400017-jlr200
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- The association between cardiorespiratory fitness and C-reactive protein in subjects with the metabolic syndromeJournal of the American College of Cardiology, 2004
- Effect of C-reactive protein on chemokine expression in human aortic endothelial cellsJournal of Molecular and Cellular Cardiology, 2004
- Inflammation in atherosclerosisNature, 2002
- Deficiency in sPLA2 does not affect HDL levels or atherosclerosis in miceBiochemical and Biophysical Research Communications, 2002
- Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifyllineMedical Hypotheses, 1999
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999
- Role of Serum Amyloid A as an Intermediate in the IL-1 and PMA-Stimulated Signaling Pathways Regulating Expression of Rabbit Fibroblast CollagenaseExperimental Cell Research, 1997
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- High-density lipoprotein inhibits the oxidative modification of low-density lipoproteinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Platelet aggregating activity of lysophosphatidic acids is not related to their calcium ionophore propertiesFEBS Letters, 1984